Charles Piller

speaker
984 appearances 4 recordings 4 series first heard Mar 2025 last heard 17 Apr

Charles Piller’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Apr OctJan 26AprJulnow

Recordings per month over the last 12 months — 2 in all, peaking in Apr 2026 with 1.

Appearances

newest first · ▶ plays the moment
Wong faced multiple charges, including major fraud against the United States, wire fraud and false statements.
A few months later, Cassava Sciences agreed to pay $40 million to the Securities and Exchange Commission to settle charges that it misled investors on the effectiveness of Simufilum.
Cassava stopped development of the drug after publicly stating that it had failed in human clinical trials, showing no cognitive advantage over a placebo.
Cassava president and CEO Remy Barbier and senior vice president and neuroscientist Lindsay Burns both resigned.
And last month, Cassava Sciences announced that it was once again changing its name, this time to Falana Therapeutics.
Haoyan Wang also agreed to pay a fine related to the SEC charges.
And in 2025, all charges of fraud made by the DOJ were dropped.
We tried to reach Wang and got no response directly, but his lawyers said they are pleased that the case against Wang was dropped in light of new evidence and maintain that Wang is innocent of the accusations made against him.
We also reached out to Falana for comment.
A spokesperson for the company said they are currently focused on researching and developing a treatment for a rare form of epilepsy.
Meanwhile, Charles Piller, as part of his book research, had been looking into the track record of many Alzheimer's researchers.
And at that time, were there any suspicions of research misbehavior or image doctoring?
Work that he's directing personally?
So you compiled this dossier that identifies 132 papers with signs of apparent image doctoring.
How do you present this information to him and what's his response?
Eliezer Maslia declined to speak with us.
And the NIH sent us a statement to say that they do not comment on personnel matters.
Coming up after the break, Matthew Schrag has a reckoning with his former mentor.
I'm Stephen Dubner.
This is Freakonomics Radio.
Showing 121–140 of 984 · page 7 of 50 ← Previous Next →